Suppr超能文献

识别高风险药物:一项系统的文献综述。

Identifying high-risk medication: a systematic literature review.

作者信息

Saedder Eva A, Brock Birgitte, Nielsen Lars Peter, Bonnerup Dorthe K, Lisby Marianne

机构信息

Department of Clinical Pharmacology, Aarhus University Hospital, Wilhelm Meyers Allé 4, 8000, Aarhus C, Denmark,

出版信息

Eur J Clin Pharmacol. 2014 Jun;70(6):637-45. doi: 10.1007/s00228-014-1668-z. Epub 2014 Mar 27.

Abstract

PURPOSE

A medication error (ME) is an error that causes damage or poses a threat of harm to a patient. Several studies have shown that only a minority of MEs actually causes harm, and this might explain why medication reviews at hospital admission reduce the number of MEs without showing an effect on length of hospital stay, readmissions, or death. The purpose of this study was to define drugs that actually cause serious MEs. We conducted a literature search of medication reviews and other preventive efforts.

METHODS

A systematic search in PubMed, Embase, Cochrane Reviews, Psycinfo, and SweMed+ was performed. Danish databases containing published patient complaints, patient compensation, and reported medication errors were also searched. Articles and case reports were included if they contained information of an ME causing a serious adverse reaction (AR) in a patient. Information concerning AR seriousness, causality, and preventability was required for inclusion.

RESULTS

This systematic literature review revealed that 47 % of all serious MEs were caused by seven drugs or drug classes: methotrexate, warfarin, nonsteroidal anti-inflammatory drugs (NSAIDS), digoxin, opioids, acetylic salicylic acid, and beta-blockers; 30 drugs or drug classes caused 82 % of all serious MEs. The top ten drugs involved in fatal events accounted for 73 % of all drugs identified.

CONCLUSION

Increasing focus on seven drugs/drug classes can potentially reduce hospitalizations, extended hospitalizations, disability, life-threatening conditions, and death by almost 50 %.

摘要

目的

用药错误(ME)是指导致患者受到损害或面临伤害风险的错误。多项研究表明,只有少数用药错误实际造成伤害,这或许可以解释为何入院时的用药评估能减少用药错误数量,但对住院时长、再入院率或死亡率并无影响。本研究的目的是确定实际导致严重用药错误的药物。我们对用药评估及其他预防措施进行了文献检索。

方法

在PubMed、Embase、Cochrane综述、Psycinfo和SweMed+中进行了系统检索。还检索了包含已发表患者投诉、患者赔偿及报告用药错误的丹麦数据库。若文章和病例报告包含用药错误导致患者出现严重不良反应(AR)的信息,则纳入研究。纳入标准要求提供有关AR严重程度、因果关系及可预防性的信息。

结果

该系统文献综述显示,所有严重用药错误中有47%由七种药物或药物类别导致:甲氨蝶呤、华法林、非甾体抗炎药(NSAIDS)、地高辛、阿片类药物、乙酰水杨酸和β受体阻滞剂;30种药物或药物类别导致了所有严重用药错误的82%。导致致命事件的前十种药物占所有已识别药物的73%。

结论

对七种药物/药物类别给予更多关注,有可能使住院、延长住院时间、残疾、危及生命的状况及死亡减少近50%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验